Corpus Intelligence IC Memo — HAYWARD AREA MEMORIAL HOSPITAL 2026-04-26 09:37 UTC
IC Memo — HAYWARD AREA MEMORIAL HOSPITAL
Investment Committee Memorandum | WI | 25 beds | Grade C | EBITDA uplift $5.4M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

HAYWARD AREA MEMORIAL HOSPITAL

CCN 521336 | SAWYER, WI | 25 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

HAYWARD AREA MEMORIAL HOSPITAL is a 25-bed suburban community hospital in SAWYER, WI with $73.4M in net patient revenue and a 7.3% operating margin. The hospital serves a payer mix of 49.4% Medicare, 10.5% Medicaid, and 40.1% commercial.

Thesis: Turnaround. Our ML models identify $5.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 7.3% to 14.7% (+736bps).

Net Revenue HCRIS$73.4M
Current EBITDA COMPUTED$5.4M
Operating Margin COMPUTED7.3%
Occupancy HCRIS44.3%
Revenue / Bed COMPUTED$2.9M
Net-to-Gross HCRIS51.0%
Distress Probability ML51.5%

2. Market Context & Competitive Position

150
WI Hospitals
0.4%
State Median Margin
87
Comparable Hospitals

WI has 150 Medicare-certified hospitals with a median operating margin of 0.4%. The target's margin of 7.3% places it above the state median. Among 87 size-comparable peers (12-50 beds), the median margin is 1.2%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 87 hospitals in the comp set.

HospitalStateBedsRevenueMargin
HAYWARD AREA MEMORIAL HOSPITAL (Target)WI25$73.4M7.3%
MERCY WALWORTH HOSPITALWI25$616.4M4.4%
ASPIRUS RIVERVIEW HOSPITAL & CWI44$161.3M13.1%
MEMORIAL MEDICAL CENTER INC.WI25$138.4M8.1%
LAKEVIEW MEDICAL CENTER OF RICWI40$137.4M-12.0%
MARSHFIELD MEDICAL CENTER-MINOWI19$129.6M-12.4%
FORT ATKINSON MEMORIAL HOSPITAWI49$127.0M-10.1%
MCHS-RED CEDARWI25$123.4M16.8%
MEMORIAL HOSPITAL OF BURLINGTOWI33$118.8M15.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $5.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.5M+210bp18mo
Cost to Collect4.5%2.5%$1.5M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.5M+198bp12mo
A/R Days Reduction5200.0%3800.0%$893K+122bp9mo
Clean Claim Rate88.0%96.0%$47K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.5M
Cost to Collect
$1.5M
Denial Rate Reduction
$1.5M
A/R Days Reduction
$893K
Clean Claim Rate
$47K
Total EBITDA Uplift$5.4M
Current EBITDA$5.4M
+ RCM Uplift+$5.4M
Pro Forma EBITDA$10.8M
Current Margin7.3%
Pro Forma Margin14.7%
WC Released (1x)$2.8M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$8.3M$89.6M10.81x61.0%
Base (11x exit)10.0x11.0x$8.3M$101.2M12.21x65.0%
Bull Case9.0x11.0x$7.5M$121.7M16.32x74.8%
Bull (12x exit)9.0x12.0x$7.5M$135.0M18.10x78.5%
Bear Case11.0x10.0x$9.1M$59.9M6.57x45.7%
Bear (11x exit)11.0x11.0x$9.1M$68.8M7.55x49.8%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighElevated distress probabilityModel estimates 51.5% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 87 hospitals with 12-50 beds
  • Same-state prioritization (n=88)
  • Comp margins: P25=-10.1% / P50=1.2% / P75=8.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.